Alcohol in America

Rorabaugh, W. J.

doi:10.1093/maghis/6.2.17

Cited by 7 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although the amendment outlawed the manufacture, sale, or transportation of alcohol, it did not prohibit consumption. 32 Before prohibition, women drank at home. However, prohibition created a substantial illegal market for alcohol.…”

Section: Women and Alcohol Use In The United States: Historical Contextmentioning

confidence: 99%

See 1 more Smart Citation

Concurrent Opioid and Alcohol Use Among Women Who Become Pregnant: Historical, Current, and Future Perspectives

Klaman

Andringa²,

Horton³

et al. 2019

Subst�Abuse

View full text Add to dashboard Cite

The numbers of women using opioids who become pregnant have captured the attention of media, research, policy, and community. At the same time, there is an ever-growing use of alcohol among women who continue drinking during pregnancy that has received less focus. Although both untreated opioid use disorder and alcohol misuse pose risks for maternal, fetal, and child morbidities, alcohol is the substance with the most significant documentation of harms. As we focus on the opioid epidemic in the United States, it is critical that we do not overlook alcohol use during pregnancy. Both opioid use and alcohol use during pregnancy are important public health challenges and often happen concurrently. Thus, this commentary aims to (1) highlight the historical and current context of opioid and alcohol use during pregnancy; (2) summarize the current knowledge of opioids and alcohol use during pregnancy; and (3) detail future directions in how health care providers can help identify and therapeutically respond to women with concurrent opioid and alcohol use disorder.

show abstract

Section: Women and Alcohol Use In The United States: Historical Contextmentioning

confidence: 99%

“…Women's recreational drinking was met with severe criticism and sitgma. 31 Although prohibition ended in 1933, 32 the stigma against women who consume alcohol continued.…”

Section: Women and Alcohol Use In The United States: Historical Contextmentioning

confidence: 99%

Concurrent Opioid and Alcohol Use Among Women Who Become Pregnant: Historical, Current, and Future Perspectives

Klaman

Andringa²,

Horton³

et al. 2019

Subst�Abuse

View full text Add to dashboard Cite

show abstract

“…Concurrently, the market economy has commercialized a wide range of products whose overuse and misuse have had severe adverse effects on human health and wellbeing [ 3 ]. Examples include cigarettes [ 4 – 6 ], sugar [ 7 – 11 ], prescription opioids [ 12 – 15 ], alcohol [ 16 – 18 ], ultra-processed foods [ 19 – 21 ], commercial milk formula (also called infant formula or breast milk substitute) [ 22 – 24 ], firearms [ 25 – 27 ], and social media [ 28 – 30 ]. Each year, such products are significant contributors to the health conditions responsible for more than 850,000 U.S. deaths and 23 million worldwide deaths [ 31 ].…”

Section: Introductionmentioning

confidence: 99%

Dynamics of combatting market-driven epidemics: Insights from U.S. reduction of cigarette, sugar, and prescription opioid consumption

Rimányi,

Quick,

Yamey

et al. 2024

PLOS Glob Public Health

View full text Add to dashboard Cite

Misuse and overconsumption of certain consumer products have become major global risk factors for premature deaths, with their total costs in trillions of dollars. Progress in reducing such deaths has been slow and difficult. To address this challenge, this review introduces the definition of market-driven epidemics (MDEs), which arise when companies aggressively market products with proven harms, deny these harms, and resist mitigation efforts. MDEs are a specific within the broader landscape of commercial determinants of health. We selected three illustrative MDE products reflecting different consumer experiences: cigarettes (nicotine delivery product), sugar (food product), and prescription opioids (medical product). Each met the MDE case definition with proven adverse health impacts, well-documented histories, longitudinal product consumption and health impact data, and sustained reduction in product consumption. Based on these epidemics, we describe five MDE phases: market expansion, evidence of harm, corporate resistance, mitigation, and market adaptation. From the peak of consumption to the most recent data, U.S. cigarette sales fell by 82%, sugar consumption by 15%, and prescription opioid prescriptions by 62%. For each, the consumption tipping point occurred when compelling evidence of harm, professional alarm, and an authoritative public health voice and/or public mobilization overcame corporate marketing and resistance efforts. The gap between suspicion of harm and the consumption tipping point ranged from one to five decades–much of which was attributable to the time required to generate sufficient evidence of harm. Market adaptation to the reduced consumption of target products had both negative and positive impacts. To our knowledge, this is the first comparative analysis of three successful efforts to change the product consumption patterns and the associated adverse health impacts of these products. The MDE epidemiological approach of shortening the latent time to effective mitigation provides a new method to reduce the impacts of harmful products.

show abstract

Introduction

Kassens¹

2019

Intemperate Spirits

View full text Add to dashboard Cite

Alcohol in America

Cited by 7 publications

References 0 publications

Concurrent Opioid and Alcohol Use Among Women Who Become Pregnant: Historical, Current, and Future Perspectives

Concurrent Opioid and Alcohol Use Among Women Who Become Pregnant: Historical, Current, and Future Perspectives

Dynamics of combatting market-driven epidemics: Insights from U.S. reduction of cigarette, sugar, and prescription opioid consumption

Introduction

Contact Info

Product

Resources

About